$VPHM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VIROPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VIROPHARMA INC. Get notifications about new insider transactions in VIROPHARMA INC for free.
Page: < prev 1 ... 7 8 9 10 11
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 303,000 | 757,500 | 4,182,000 | |
| Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 137,000 | 342,500 | 3,879,000 | |
| Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 344,000 | 860,000 | 3,742,000 | |
| Feb 15 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (Z) ... | 10% Owner | Option Exercise | P | 2.50 | 22,000 | 55,000 | 209,000 | |
| Feb 15 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (Z) ... | 10% Owner | Option Exercise | P | 2.50 | 67,000 | 167,500 | 187,000 | |
| Feb 15 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (Z) ... | 10% Owner | Option Exercise | P | 2.50 | 31,000 | 77,500 | 120,000 | |
| Feb 15 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (Z) ... | 10% Owner | Buy | P | 3.02 | 451 | 1,362 | 451 | 0 to 451 |
| Feb 14 2005 | VPHM | VIROPHARMA INC | 14159 Capital (GP, LLC | 10% Owner | Option Exercise | P | 2.50 | 10,000 | 25,000 | 91,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | 14159 Capital (GP, LLC | 10% Owner | Option Exercise | P | 2.50 | 29,000 | 72,500 | 81,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | 14159 Capital (GP, LLC | 10% Owner | Option Exercise | P | 2.50 | 14,000 | 35,000 | 52,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | 14159 Capital (GP, LLC | 10% Owner | Buy | P | 3.02 | 193 | 583 | 193 | 0 to 193 |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 30,000 | 75,000 | 382,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 90,000 | 225,000 | 352,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 42,000 | 105,000 | 262,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Buy | P | 3.02 | 605 | 1,827 | 605 | 0 to 605 |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 116,000 | 290,000 | 2,829,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 348,000 | 870,000 | 2,713,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 163,000 | 407,500 | 2,365,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Buy | P | 3.02 | 2,348 | 7,090 | 2,348 | 0 to 2.3 K |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 15,000 | 37,500 | 375,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 45,000 | 112,500 | 360,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 21,000 | 52,500 | 315,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Buy | P | 3.02 | 301 | 909 | 301 | 0 to 301 |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 150,000 | 375,000 | 3,738,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 450,000 | 1,125,000 | 3,588,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 210,000 | 525,000 | 3,138,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL GP LLC | 10% Owner | Buy | P | 3.02 | 3,036 | 9,167 | 3,036 | 0 to 3 K |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Option Exercise | P | 2.50 | 19,000 | 47,500 | 178,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Option Exercise | P | 2.50 | 57,000 | 142,500 | 159,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Option Exercise | P | 2.50 | 26,000 | 65,000 | 102,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Buy | P | 3.02 | 384 | 1,159 | 384 | 0 to 384 |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 10,000 | 25,000 | 91,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 29,000 | 72,500 | 81,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 14,000 | 35,000 | 52,000 | |
| Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Buy | P | 3.02 | 193 | 583 | 193 | 0 to 193 |
| Feb 10 2005 | VPHM | VIROPHARMA INC | BALDINO FRANK JR | Director | Option Exercise | A | 3.00 | 25,000 | 75,000 | 25,000 | |
| Feb 10 2005 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | A | 3.00 | 25,000 | 75,000 | 25,000 | |
| Feb 10 2005 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | A | 3.00 | 25,000 | 75,000 | 25,000 | |
| Feb 10 2005 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 3.00 | 25,000 | 75,000 | 25,000 | |
| Jan 25 2005 | VPHM | VIROPHARMA INC | DE ROSEN MICHEL | Chief Executive Off ... | Option Exercise | A | 3.14 | 120,000 | 376,800 | 120,000 | |
| Feb 10 2005 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | A | 3.00 | 25,000 | 75,000 | 25,000 | |
| Jan 25 2005 | VPHM | VIROPHARMA INC | MILANO VINCENT | VP, Chief Financial ... | Option Exercise | A | 3.14 | 60,000 | 188,400 | 60,000 | |
| Jan 25 2005 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 3.14 | 60,000 | 188,400 | 60,000 | |
| Jan 25 2005 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP, General Counsel | Option Exercise | A | 3.14 | 60,000 | 188,400 | 60,000 | |
| Jan 25 2005 | VPHM | VIROPHARMA INC | Tarnoff Joshua M | VP, Commerical Oper ... | Option Exercise | A | 3.14 | 40,000 | 125,600 | 40,000 | |
| Aug 26 2004 | VPHM | VIROPHARMA INC | Tarnoff Joshua M | VP, Commercial | Option Exercise | A | 2.44 | 60,000 | 146,400 | 60,000 | |
| May 12 2004 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 1.84 | 150,000 | 276,000 | 150,000 | |
| May 12 2004 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 1.84 | 150,000 | 276,000 | 150,000 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | A | 2.09 | 15,000 | 31,350 | 15,000 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | D | 2.09 | 15,000 | 31,350 | 0 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | A | 2.09 | 15,000 | 31,350 | 15,000 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | D | 2.09 | 15,000 | 31,350 | 0 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | A | 0.99 | 1 | 1 | 1 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | D | 0.99 | 1 | 1 | 0 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | A | 0.99 | 59,999 | 59,399 | 59,999 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | D | 0.99 | 59,999 | 59,399 | 0 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | A | 3.93 | 4 | 16 | 4 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | D | 3.93 | 4 | 16 | 0 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | A | 3.93 | 19,996 | 78,584 | 19,996 | |
| Apr 13 2004 | VPHM | VIROPHARMA INC | MCKINLAY MARK | VP Research & Devel ... | Option Exercise | D | 3.93 | 19,996 | 78,584 | 0 | |
| Mar 22 2004 | VPHM | VIROPHARMA INC | FARLEY RICHARD | VP, Human Resources | Option Exercise | A | 2.09 | 15,000 | 31,350 | 15,000 | |
| Mar 22 2004 | VPHM | VIROPHARMA INC | FARLEY RICHARD | VP, Human Resources | Option Exercise | D | 2.09 | 15,000 | 31,350 | 0 | |
| Mar 22 2004 | VPHM | VIROPHARMA INC | FARLEY RICHARD | VP, Human Resources | Option Exercise | A | 0.99 | 49,994 | 49,494 | 49,994 | |
| Mar 22 2004 | VPHM | VIROPHARMA INC | FARLEY RICHARD | VP, Human Resources | Option Exercise | D | 0.99 | 49,994 | 49,494 | 0 | |
| Feb 05 2004 | VPHM | VIROPHARMA INC | DE ROSEN MICHEL | Chief Executive Off ... | Option Exercise | A | 2.71 | 200,000 | 542,000 | 200,000 | |
| Jan 14 2004 | VPHM | VIROPHARMA INC | AVENTIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 3.49 | 31,000 | 108,190 | 2,638,100 | 2.7 M to 2.6 M (-1.16 %) |
| Jan 14 2004 | VPHM | VIROPHARMA INC | AVENTIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 3.36 | 95,900 | 322,224 | 2,669,100 | 2.8 M to 2.7 M (-3.47 %) |
| Jan 16 2004 | VPHM | VIROPHARMA INC | AVENTIS PHARMACEUTICALS INC | Sell | S | 3.51 | 22,100 | 77,571 | 2,616,000 | 2.6 M to 2.6 M (-0.84 %) | |
| Jan 12 2004 | VPHM | VIROPHARMA INC | AVENTIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 3.18 | 59,000 | 187,620 | 2,765,000 | 2.8 M to 2.8 M (-2.09 %) |
| Nov 26 2003 | VPHM | VIROPHARMA INC | AVENTIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 3.15 | 15,012 | 47,288 | 2,824,000 | 2.8 M to 2.8 M (-0.53 %) |
| Nov 05 2003 | VPHM | VIROPHARMA INC | AVENTIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 3.30 | 25,988 | 85,760 | 2,839,012 | 2.9 M to 2.8 M (-0.91 %) |
| Nov 05 2003 | VPHM | VIROPHARMA INC | AVENTIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 3.17 | 135,000 | 427,950 | 2,865,000 | 3 M to 2.9 M (-4.50 %) |